Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Mebazaa

Showing results (121-130 of 792) with videos related to

Pageof 80
Sort By:
Heart Failure Reviews|December 2, 2021
Immunity and inflammation: the neglected key players in congenital heart disease?Laura M Wienecke, Sarah Cohen, Johann Bauersachs, et al.
Shock (Augusta, Ga.)|October 10, 2021
Plasmatic NGAL Monitoring in Cardiogenic Shock: Deciphering the Past, the Present, and the FutureCharles de Roquetaillade, Benjamin Glenn Chousterman, François Dépret, et al.
Cardiac Failure Review|February 28, 2025
Counteracting the Mechanisms of Heart Failure is the Most Effective Way to Decongest Patients while Improving OutcomesJelena Čelutkienė, Alexandre Mebazaa, Jan Biegus, et al.
European Journal of Internal Medicine|February 17, 2016
Heterogeneity of the prognostic significance of B-type natriuretic peptide levels on admission in patients hospitalized for acute heart failure syndromesYuichiro Minami, Katsuya Kajimoto, Naoki Sato, et al.
Annals of the New York Academy of Sciences|March 6, 2010
Molecular mechanisms in evolutionary cardiology failureBernard Swynghedauw, Claude Delcayre, Jane-Lyse Samuel, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|June 27, 2018
Methods used to assess the performance of biomarkers for the diagnosis of acute kidney injury: a systematic review and meta-analysisAnaïs Codorniu, Léa Lemasle, Matthieu Legrand, et al.
European Heart Journal. Acute Cardiovascular Care|June 30, 2026
Beyond Trial Design: How a New Global Generation of Trialists Is Shaping the Future of Cardiogenic Shock ResearchHannah Schaubroeck, Thevathasan Tharusan, Rebecca Mathew, et al.
European Heart Journal. Acute Cardiovascular Care|July 10, 2024
Science pulse: management of cardiogenic shock and trial design: time for a paradigm shift! Insights from the Critical Care Clinical Trialists meetingJanine Pöss, Hannah Schaubroeck, Mattia Arigo, et al.
Intensive Care Medicine Experimental|June 7, 2020
Analysis of blood culture in a rat model of cecal ligation and puncture induced sepsisPrabakar Vaittinada Ayar, Hervé Jacquier, Benjamin Deniau, et al.
European Heart Journal. Case Reports|October 30, 2019
Evolution of B-type natriuretic peptide and N-terminal pro-brain natriuretic peptide during acute decompensated heart failure in a chronic heart failure patient with reduced ejection fraction treated with Sacubitril/Valsartan: a case reportAmbre Tiepolo, Hélène Nougué, Charles Damoisel, et al.
Pageof 80

Showing results (121-130 of 792) with videos related to

Sort By:
Pageof 80
Heart Failure Reviews|December 2, 2021
Immunity and inflammation: the neglected key players in congenital heart disease?Laura M Wienecke, Sarah Cohen, Johann Bauersachs, et al.
Shock (Augusta, Ga.)|October 10, 2021
Plasmatic NGAL Monitoring in Cardiogenic Shock: Deciphering the Past, the Present, and the FutureCharles de Roquetaillade, Benjamin Glenn Chousterman, François Dépret, et al.
Cardiac Failure Review|February 28, 2025
Counteracting the Mechanisms of Heart Failure is the Most Effective Way to Decongest Patients while Improving OutcomesJelena Čelutkienė, Alexandre Mebazaa, Jan Biegus, et al.
European Journal of Internal Medicine|February 17, 2016
Heterogeneity of the prognostic significance of B-type natriuretic peptide levels on admission in patients hospitalized for acute heart failure syndromesYuichiro Minami, Katsuya Kajimoto, Naoki Sato, et al.
Annals of the New York Academy of Sciences|March 6, 2010
Molecular mechanisms in evolutionary cardiology failureBernard Swynghedauw, Claude Delcayre, Jane-Lyse Samuel, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|June 27, 2018
Methods used to assess the performance of biomarkers for the diagnosis of acute kidney injury: a systematic review and meta-analysisAnaïs Codorniu, Léa Lemasle, Matthieu Legrand, et al.
European Heart Journal. Acute Cardiovascular Care|June 30, 2026
Beyond Trial Design: How a New Global Generation of Trialists Is Shaping the Future of Cardiogenic Shock ResearchHannah Schaubroeck, Thevathasan Tharusan, Rebecca Mathew, et al.
European Heart Journal. Acute Cardiovascular Care|July 10, 2024
Science pulse: management of cardiogenic shock and trial design: time for a paradigm shift! Insights from the Critical Care Clinical Trialists meetingJanine Pöss, Hannah Schaubroeck, Mattia Arigo, et al.
Intensive Care Medicine Experimental|June 7, 2020
Analysis of blood culture in a rat model of cecal ligation and puncture induced sepsisPrabakar Vaittinada Ayar, Hervé Jacquier, Benjamin Deniau, et al.
European Heart Journal. Case Reports|October 30, 2019
Evolution of B-type natriuretic peptide and N-terminal pro-brain natriuretic peptide during acute decompensated heart failure in a chronic heart failure patient with reduced ejection fraction treated with Sacubitril/Valsartan: a case reportAmbre Tiepolo, Hélène Nougué, Charles Damoisel, et al.
Pageof 80